Collapse from exertional heat illness: Implications and subsequent decisions

Military Medicine

Volumn 168, Issue 1, 2003, Pages 76-81

  Porter, Alan M W ^a  

^a Redcrest   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; BODY TEMPERATURE; COLLAPSE; EXERCISE; EXERCISE TEST; EXERTIONAL HEAT ILLNESS; GENE MUTATION; HEAT STRESS; HERITABILITY; HIGH RISK POPULATION; HUMAN; MALE; MALIGNANT HYPERTHERMIA; RISK FACTOR; SOLDIER;

EID: 0037226839     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.1093/milmed/168.1.76     Document Type: Article

References (44)

1. Reynolds NC, Schumaker HD: Complications of fluid overload in heat casualty prevention during field training. Milit Med 1998; 163: 789-91.
2. O'Brien KK, Montain SJ, Corr WP, Sawka MN, Knapik JJ, Craig SC: Hyponatremia associated with overhydration in U.S. army trainees. Milit Med 2001; 166: 405-10.
3. Gardner JW, Kark JA: Fatal rhabdomyolysis presenting as mild heat illness in military training. Milit Med 1994; 159: 160-63.
4. Armstrong LE, Hubbard RW: Application of a model of exertional heatstroke pathophysiology to cocaine intoxication. Am J Emerg Med 1990; 8: 178. Letter.
5. Bodenham AR, Mallik A: New dimensions in toxicology: hyperthermic syndrome following amphetamine derivatives. Int Care Med 1996; 22: 622-4.
6. Porter AMW: The death of a British officer-cadet from heat illness. Lancet 2000; 355: 569-71.
7. Gardner JW, et al: Risk factors predicting exertional heat illness in male Marine Corps recruits. Med Sci Sports Exerc 1996; 28: 939-44.
8. Epstein Y, Moran DS, Shapiro Y, Sohar E, Shemer J: Exertional heat stroke: a case series. Med Sel Sports Exerc 1999; 31: 224-8.
9. Epstein Y, Shapiro Y, Brill S: Role of surface area-to-mass ratio and work efficiency in heat intolerance. J Appl Physiol 1983; 54: 831-6.
10. Hayward JS, Eckerson JD, Dawson BT: Effect of mesomorphy on hyperthermia during exercise in a warm, humid environment. Am J Phys Anthrop 1986; 70: 11-17.
11. Porter AMW: Heat illness and army recruits. Lancet 1986; 1: 215-16.
12. Epstein Y, Shani Y, Moran DS, Shapiro Y: Exertional heatstroke: the prevention of a medical emergency. J Basic Clin Physiol Pharmacol 2000; 11: 395-401.
13. Phinney LT, Gardner JW, Kark JA, Wenger CB: Long-term follow-up after exertional heat illness during recruit training. Med Sci Sports Exerc 2001; 33: 1143-8.
14. Shani Y, Moran DS, Heled Y, Shapiro Y, Epstein Y: Exertional heat illness. Lancet 2000; 355: 1992-3. Letter.
15. Shapiro Y, Magazanic A, Udassin R, Ben-Baruch G, Sharvtz E, Shoenfeld Y: Heat intolerance in former heatstroke patients. Ann Intern Med 1979; 90: 913-16.
16. Abraham RB, Adnet P, Glauber V, Perel A: Malignant hyperthermia. Postgrad Med J 1998; 74: 11-17.
17. Denborough M: Malignant hyperthermia. Lancet 1998; 352: 1131-6.
18. Hopkins PM: Malignant hyperthermia: advances in clinical management and diagnosis. Br J Anaesth 2000; 85: 118-28,
19. Halsall PJ, Cain PA, Ellis FR: Retrospective analysis of anaesthetics received by patients before susceptibility to malignant hyperpyrexia was recognised. Br J Anaesth 1979; 51: 949-54.
20. Bendixen D, Skovgaard LT, Ording H: Analysis of anaesthesia in patients suspected to be susceptible to malignant hyperthermia before diagnostic in vitro contracture test. Acta Anaesthesiol Scand 1997; 41: 480-4.
21. Wappler F, et al: Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis. Anesthesiology 2001; 94: 95-100.
22. McPherson E, Taylor CA: The genetics of malignant hyperthermia: evidence for heterogeneity. Am J Med Genet 1982; 11: 273-85.
23. Sambuughin N, McWilliams S, de Bantel A, Sivakumar K, Nelson TE: Single-amino-acid deletion in the RYR1 gene, associated with malignant hyperthermia susceptibility and unusual contraction phenotype. Am J Hum Genet 2001; 69: 204-8.
24. 2+ release channels. Am J Med 1998; 104: 470-86.
25. Kalow W, Britt BA, Terreau ME, Haist C: Metabolic error of muscle metabolism after recovery from malignant hyperthermia, Lancet 1970; 2: 895-8.
26. Rankley E, Fletcher R. Krantz P: Malignant hyperpyrexia and sudden death. Am J Forensic Med Pathol 1985; 6: 149-50.
27. Ording H, et al: In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group. Acta Anaesthesiol Scand 1997; 41: 955-66.
28. Allen GC, Larach MG, Kuselman AR: The sensitivity and specificity of the caffeine-halothane contracture test: a report from the North American Malignant Hyperthermia Registry. Anesthesiology 1998; 88: 579-88.
29. Larah MG, MacLennan DH. Editorial: How carefully can we phenotype patients suspected of malignant hyperthermia susceptibility? Anesthesiology 1999; 90: 645-8.
30. Ording H, Hald A, Sjontoft E: Malignant hyperthermia triggered by heating in anaesthetised pigs. Acta Anaesthesiol Scand 1985; 29: 698-701.
31. Payen JF, et al: Exertional heatstroke and muscle metabolism: an in vivo 31P-MRS study. Med Sci Sports Exerc 1992; 24: 420-5.
32. Denborough MA: Heat stroke and malignant hyperpyrexia. Med J Aust 1982; 6: 204-5. Letter.
33. Hackl W, Winkler M, Mauritz W, Sporn P, Steinbereithner. K: Muscle biopsy for diagnosis of malignant hyperthermia susceptibility in two patients with severe exercise-induced myolysis. Br J Anaesth 1991; 66: 138-40.
34. Hopkins PM, Ellis FR, Halsall PJ: Evidence for related myopathies in exertional heat stroke and malignant hyperthermia. Lancet 1991; 338: 1491-2.
35. Figarella-Branger D, et al: Pathological findings in 165 patients explored for malignant hyperthermia susceptibility. Neuromuscul Disord 1993; 3: 553-6.
36. Kochling A, Wappler F, Winkler G, Schulte J: Rhabdomyosis following severe physical exercise in a patient with predisposition to malignant hyperthermia. Anaesth Intensive Care 1998; 26: 315-18.
37. Bendahan D, et al: A noninvasive investigation of muscle energetics supports similarities between exertional heat stroke and malignant hyperthermia. Anesth Analg 2001; 93: 683-9.
38. Anetseder M, Hager M, Mfller CR, Roewer N: Diagnosis of susceptibility to malignant hyperthermia by use of a metabolic test. Lancet 2002; 359: 1579-80.
39. Heraut LA, Poujol C, Bouche P, Fardeau M, Cathala HP: L'hyperthermie mallgne d'effort. Anomalies électromyographiques d'aspect myogène: Dix observations. Presse Med 1983; 12: 2737-40.
40. Tobin JR, Jason DR, Nelson TE, Sambuughin N: Malignant hyperthermia and apparent heat stroke. JAMA 2001; 286: 168-9. Letter.
41. Bouchama A, Hussain S: Malignant hyperthermia. Lancet 1998; 352: 1785. Letter.
42. Channa AB, Seraj MA, Saddique AA, et al: Is dantrolene effective in heat stroke patients? Crit Care Med 1990; 18: 290-2.
43. Bouchama A, Cafege A, Devol EB, Labdi O, El-Assil K, Seraj M: Ineffectiveness of dantrolene sodium in the treatment of heatstroke. Crit Care Med 1991; 19: 176-80.
44. Lydiatt JS, Hill GE: Treatment of heat stroke with dantrolene. JAMA 1981; 246: 41-2. Letter.